May 22, 2020 / 2:10 AM / 11 days ago

BRIEF-Tetraphase Says Latest Proposal From Melinta Therapeutics To Acquire Co Is A "Superior Offer"

May 21 (Reuters) - Tetraphase Pharmaceuticals Inc:

* TETRAPHASE ANNOUNCES DETERMINATION OF SUPERIOR OFFER AND NOTICE TO ACELRX

* TETRAPHASE PHARMACEUTICALS INC - BOARD DETERMINED THAT LATEST PROPOSAL FROM MELINTA THERAPEUTICS TO ACQUIRE CO IS A “SUPERIOR OFFER”

* TETRAPHASE - GIVEN NOTICE TO ACELRX OF SUCH DETERMINATION, INTENTION TO CONSIDER CHANGING RECOMMENDATION OF ACELRX MERGER AGREEMENT/ TERMINATING IT

* TETRAPHASE - CHANGING /TERMINATING ACELRX MERGER AGREEMENT UNLESS ACELRX PROPOSES REVISIONS/ MAKES ANOTHER PROPOSAL ON/ PRIOR TO MAY 29

* TETRAPHASE PHARMACEUTICALS INC - AT THIS TIME, TETRAPHASE BOARD HAS NOT CHANGED ITS RECOMMENDATION WITH RESPECT TO PENDING TRANSACTION WITH ACELRX Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below